Newsletter
Every new paper in this field, in your inbox.
Researchers examined the role of mesenteric lymph nodes (MLNs) in digestive resection for advanced ovarian cancer (OC) with peritoneal metastases. Out of 159 patients, 77 underwent digestive resection, with 61.1% having MLNs examined, and 56.8% showed involvement. Surprisingly, MLN status didn't significantly impact overall survival…
When dealing with recurring mucinous appendiceal adenocarcinoma, undergoing repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be a game-changer. This study from MD Anderson Cancer Center reveals that patients who opt for repeat CRS/HIPEC enjoy similar recurrence-free survival compared to those initially treated,…
In patients with colorectal peritoneal metastases (CRC-PM) treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), systemic chemotherapy (SC) did not significantly enhance overall survival (OS). However, the timing of SC made a difference. Preoperative SC correlated with more major complications and shorter disease-free intervals,…
